No difference in oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving radical nephroureterectomy.
Tsu-Chen LinGuan-Heng ChenChin-Chung YehHung-Lung KeWei-Ming LiYao-Chou TsaiShu-Yu WuChao-Yuan HuangChung-Hsin ChenWun-Rong LinMarcelo ChenShih-Hsiu LoSee-Tong PangPo Hung LinPublished in: Scientific reports (2024)
Patients with end stage renal disease (ESRD) are at high risk of developing upper tract urothelial carcinoma (UTUC). Due to high recurrence rate of UTUC in contralateral kidney and ureter, and high risk of complications related to surgery and anesthesia, whether it's necessary to remove both kineys and ureters at one time remains in debate. We utilized Taiwanese UTUC Registry Database to valuate the difference of oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving surgical resection. Patients with ESRD and UTUC were divided into three groups, unilateral UTUC, previous history of unilateral UTUC with metachronous contralateral UTUC, and concurrent bilatetral UTUC. Oncological outcomes, perioperative complications, and length of hospital stays were investiaged. We found that there is no diffence of oncological outcomes including overall survival, cancer specific survival, disease free survival and bladder recurrence free survival between these three groups. Complication rate and length of hospital stay are similar. Adverse oncological features such as advanced tumor stage, lymph node involvement, lymphovascular invasion, and positive surgical margin would negatively affect oncological outcomes.
Keyphrases
- free survival
- end stage renal disease
- chronic kidney disease
- rectal cancer
- radical prostatectomy
- lymph node
- healthcare
- robot assisted
- cardiac surgery
- risk factors
- prostate cancer
- minimally invasive
- spinal cord injury
- emergency department
- squamous cell carcinoma
- coronary artery disease
- adipose tissue
- young adults
- glycemic control
- skeletal muscle
- radiation therapy
- neoadjuvant chemotherapy
- atrial fibrillation
- cell migration
- papillary thyroid
- sentinel lymph node
- endometrial cancer